Media & Insight
We underwrite technical risk with a first principles approach, investing at the earliest stages in transformative companies where deep technical innovation can solve the world’s most challenging problems.
How Wyatt McDonnell is revolutionizing antibody therapeutics — and what that means for the future of patient care
January 14, 2025